Fennec Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 121.3 | 60.9 | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,045.8 | 948.3 | 1,116.6 | 1,438.0 | – | – | – | – | 164.9 | 68.6 | 35.6 | 15.3 | 14.1 | 7.7 | 3.4 | 2.8 | 3.6 | 5.4 | 6.9 | 6.8 | 5.4 | 4.3 | 6.6 | |
| 6.8 | 7.5 | 14.8 | 9.4 | 19.7 | 5.7 | 8.7 | 7.8 | 6.8 | 6.0 | 5.1 | 4.8 | 6.4 | 11.0 | 13.9 | 5.4 | 5.0 | 6.1 | 6.5 | 8.5 | 12.9 | 7.3 | 11.6 | 17.1 | 75.5 | – | – | – | – | – | 114.5 | – | – | – | – | – | – | 6.8 | 5.8 | 9.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 985.5 | 1,324.3 | – | – | – | – | 165.6 | 70.6 | 37.2 | 16.3 | 15.0 | 7.2 | 3.2 | 2.6 | 3.5 | 5.3 | 6.9 | 6.7 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 44.3 | 21.0 | 34.5 | 34.5 | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 12.6 | 7.2 | 5.8 | 6.4 | – | – | – | – | – | – | |
| -6.8% | -7.9% | -5.4% | -2.8% | -1.7% | -2.4% | -2.1% | -2.9% | -4.0% | -6.1% | -8.8% | -12.3% | -10.9% | -6.9% | -8.8% | -5.4% | -8.9% | -8.8% | -9.6% | -8.8% | -5.8% | -12.4% | -9.3% | -8.5% | -6.9% | -7.1% | -9.4% | -9.2% | -9.6% | -5.7% | 8.0% | 13.8% | 17.2% | 15.6% | -9.7% | -5.1% | -3.0% | -5.2% | -2.6% | -0.5% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 94.9% | 94.8% | 95.3% | 95.6% | 94.1% | 96.2% | 95.6% | 93.5% | 93.3% | 90.3% | 89.9% | 93.1% | 91.6% | 92.2% | 93.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -10,520.6% | -11,160.6% | -10,616.5% | -9,624.7% | – | – | – | – | -1,471.6% | -756.9% | -366.7% | -130.9% | -60.1% | 13.9% | 12.0% | 3.4% | 5.3% | -39.0% | -29.2% | -12.2% | -14.2% | -11.0% | -2.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -10,652.4% | -11,185.9% | -10,689.4% | -9,504.1% | – | – | – | – | -1,544.9% | -811.6% | -404.5% | -154.9% | -75.5% | 6.3% | 5.6% | -2.3% | -0.9% | -46.7% | -36.1% | -17.9% | -21.8% | -16.4% | -5.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -9,173.5% | -9,081.8% | -9,852.4% | -8,388.8% | – | – | – | – | -1,176.4% | -646.9% | -326.4% | -146.2% | -80.7% | 61.1% | 47.1% | 47.8% | 56.8% | -53.0% | -35.1% | -20.6% | -27.9% | -11.3% | -3.4% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -51.8% | -78.1% | -111.0% | -41.8% | -66.6% | -26.3% | -30.4% | -35.4% | -40.2% | -46.4% | -57.0% | -79.4% | -81.0% | -107.6% | -165.2% | -39.0% | -59.3% | -62.3% | -76.3% | -81.6% | -85.0% | -110.0% | -130.2% | -203.5% | -759.6% | – | – | – | – | – | 94.4% | – | – | – | – | – | – | -27.5% | -22.2% | -7.7% | |
| -47.7% | -70.2% | -96.6% | -39.5% | -59.7% | -24.8% | -29.1% | -34.2% | -36.9% | -43.1% | -53.0% | -73.4% | -76.4% | -90.3% | -134.8% | -35.8% | -54.2% | -57.6% | -68.3% | -64.6% | -62.1% | -77.4% | -85.2% | -111.6% | -70.0% | -88.0% | -119.5% | -136.0% | -106.3% | -59.7% | 4.1% | 4.3% | -1.9% | -1.0% | -31.1% | -26.8% | -14.1% | -13.8% | -11.7% | -4.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -4.5 | -3.9 | -3.2 | -10 | -9.3 | -28 | -27 | -26 | -25 | – | – | – | – | – | – | – | – | – | – | -22 | -19 | -16 | -13 | -9.9 | -5.1 | 1.1 | 6.3 | 10 | 13 | 18 | -20 | -11 | -8.2 | -7.3 | -3.3 | 0.7 | -2.6 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.7 | -1.5 | -2.2 | -1.5 | – | – | – | – | – | – | |
| 92.1% | 89.9% | 87.0% | 94.3% | 89.6% | 94.2% | 95.6% | 96.7% | 91.7% | 92.9% | 93.0% | 92.4% | 94.3% | 83.9% | 81.6% | 91.9% | 91.5% | 92.5% | 89.6% | 79.2% | 73.1% | 70.4% | 65.4% | 54.9% | 9.2% | -9.5% | -33.6% | -50.0% | -55.3% | -43.3% | 4.4% | -2.1% | -8.8% | -13.1% | -12.7% | -16.6% | -9.1% | 50.3% | 52.5% | 56.0% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | 0.2 | 0.3 | 0.3 | 0.4 | 0.6 | 8.8 | – | – | – | – | – | 10.4 | – | – | – | – | – | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.16 | -0.22 | -0.23 | -0.29 | -0.37 | -0.46 | -0.42 | -0.47 | -0.48 | -0.50 | -0.55 | -0.66 | -0.61 | -0.64 | -0.70 | -0.60 | -0.72 | -0.76 | -0.73 | -0.70 | -0.62 | -0.67 | -0.63 | -0.67 | -0.82 | -0.90 | -0.98 | -1.00 | -0.76 | -0.60 | 0.09 | 0.10 | -0.04 | -0.02 | -0.52 | -0.44 | -0.25 | -0.31 | -0.24 | -0.09 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.12 | 0.25 | 0.49 | 0.79 | 1.45 | 1.79 | 1.80 | 1.73 | 1.12 | 1.20 | 1.39 | 1.43 | 1.43 | 1.63 | |
| 0.31 | 0.28 | 0.21 | 0.68 | 0.56 | 1.75 | 1.39 | 1.34 | 1.21 | 1.07 | 0.97 | 0.83 | 0.75 | 0.59 | 0.43 | 1.54 | 1.22 | 1.23 | 0.96 | 0.86 | 0.73 | 0.61 | 0.48 | 0.33 | 0.11 | -0.10 | -0.28 | -0.37 | -0.40 | -0.43 | 0.10 | -0.05 | -0.19 | -0.21 | -0.21 | -0.27 | -0.16 | 1.14 | 1.06 | 1.17 | |
| -0.14 | -0.17 | -0.17 | -0.18 | -0.19 | -0.24 | -0.25 | -0.30 | -0.33 | -0.39 | -0.43 | -0.49 | -0.52 | -0.45 | -0.52 | -0.46 | -0.54 | -0.66 | -0.59 | -0.64 | -0.55 | -0.55 | -0.52 | -0.48 | -0.56 | -0.69 | -0.78 | -0.81 | -0.72 | -0.64 | 0.88 | 0.84 | 0.86 | 0.98 | -0.59 | -0.42 | -0.29 | -0.40 | -0.16 | -0.06 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.